So, Dacomitinib’s a drug that’s really good for NSCLC patients with either the 19th exon deleted or the L858R mutation on the 21st exon. It works by stopping the EGFR pathway from doing its thing. You can get it in different strengths, like 15 mg, 30 mg, or 45 mg, all in those film-coated tablets.
They usually recommend taking 45 mg of it once a day. The tablets come in bottles, each holding 30 pills.
Reviews
There are no reviews yet.